Summary & Overview
HCPCS A4722: Dialysate Solution for Peritoneal Dialysis (2000–2999 cc)
HCPCS Level II code A4722 designates a dialysate solution for peritoneal dialysis containing any concentration of dextrose in a fluid volume greater than 1999 cc up to 2999 cc. This supply code is relevant to home-based and outpatient peritoneal dialysis programs and affects billing for consumable dialysis fluids used in exchanges. Nationally, peritoneal dialysis supplies influence payment flows for chronic kidney disease management and home dialysis adoption efforts.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines coverage and billing considerations across these major payers, and presents benchmarks and policy context for dialysate supply reimbursement. Readers will find a clinical and billing context for A4722, typical service settings, common modifiers and payer considerations, and guidance on where to locate applicable policy language.
The report also summarizes available benchmarks and recent policy updates affecting peritoneal dialysis supplies, and highlights operational issues such as documentation and claim line reporting. Data not provided in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code A4722 describes a dialysate solution for peritoneal dialysis, specified as any concentration of dextrose in a fluid volume greater than 1999 cc but less than or equal to 2999 cc. This item represents the dialysis fluid supplied for instillation into the peritoneal cavity to facilitate solute and fluid exchange during peritoneal dialysis therapy.
Service Type: Peritoneal dialysis supply (dialysate solution)
Typical Site of Service: Home or outpatient dialysis setting, where peritoneal dialysis exchanges are performed by the patient or a caregiver, or in outpatient clinics that provide peritoneal dialysis services.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with end-stage renal disease (ESRD) on chronic ambulatory peritoneal dialysis (CAPD) presents for routine home dialysis exchange using a prepackaged dialysis fluid bag containing between 2000 cc and 2999 cc of dialysate with dextrose. The supply is delivered and documented by the dialysis nurse or home health clinician. The typical workflow includes verification of the prescribed dextrose concentration (to achieve ultrafiltration goals), inspection of the fluid bag for integrity and expiration, hand hygiene and aseptic connector technique, drainage of spent dialysate from the peritoneal cavity, instillation of the A4722 volume bag, monitoring dwell time and patient tolerance, and documentation of volume instilled, dwell time, and any complications (e.g., exit-site infection, peritonitis symptoms, or catheter malfunction). The typical site of service is outpatient dialysis units, home dialysis settings, and occasionally inpatient hospital wards when peritoneal dialysis is continued during admission. The patient scenario frequently involves coordination among nephrology, home dialysis nursing, and durable medical equipment suppliers for ongoing provision of A4722 dialysate solution.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies to the service. |